Ontuxizumab

From WikiMD's WELLNESSPEDIA

Ontuxizumab is a monoclonal antibody designed for the treatment of cancer. This drug was developed by Morphotek.

History[edit]

Ontuxizumab was developed by Morphotek, a subsidiary of Eisai Co.. The drug is a monoclonal antibody that targets endosialin, a protein that is overexpressed in many types of cancer.

Mechanism of Action[edit]

Ontuxizumab works by targeting endosialin, a protein that is overexpressed in many types of cancer. By binding to this protein, ontuxizumab can inhibit the growth and spread of cancer cells.

Clinical Trials[edit]

Ontuxizumab has been tested in several clinical trials for its effectiveness in treating various types of cancer. These trials have shown promising results, but further research is needed to confirm these findings.

Side Effects[edit]

Like all drugs, ontuxizumab can cause side effects. The most common side effects reported in clinical trials include fatigue, nausea, and decreased appetite. More serious side effects can also occur, but these are less common.

See Also[edit]

References[edit]


Stub icon

This WikiMD article can only be edited by registered and verified editors. You can log in or register.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Ontuxizumab&oldid=6525421"